Cannabis Use Disorder – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Cannabis as a Schedule I drug is classified by the FDA. The usage of cannabis exhibits variations across different demographic groups. Tetrahydrocannabinol (THC) serves as the primary compound responsible for the reinforcing effects of marijuana. Although the striatal dopamine system typically plays a role in substances of abuse, such as alcohol and opioids, current meta-analyses lack sufficient evidence to support a similar conclusion regarding cannabis. The Diagnostic and Statistical Manual of Mental Disorders (DSM–5) has updated the criteria for cannabis use disorder, delineating nine pathological patterns categorized under impaired control, social impairment, risky behavior, or physiological adaptation. It is focused on cannabis misuse and its associated elements, including states of intoxication, withdrawal, and cannabis use disorder. Moreover, dopamine receptors may not be directly involved. The primary objective is to enhance the overall function...